86.22.Z - Specialist medical practice
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.66.Z - Wholesale trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
69.20.Z - Accounting, bookkeeping and tax consultancy
72.19.Z - Scientific research and development activities
85.59 - Other non-school forms of education, not classified elsewhere
86.21.Z - General medical practice
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | 0 | 0 | -88 |
EBITDA | ||||
Short time liabilities | 1,3 | 0,5 | 0,4 | -28,5 |
Equity capital | 0 | 0,1 | 0,1 | 2,3 |
Operating profit (EBIT) | 0 | 0 | 0 | -88 |
Assets | 1,4 | 0,6 | 0,4 | -25,3 |
Net profit (loss) | 0 | 0 | 0 | -95 |
Cash | 0,1 | 0,5 | 0,3 | -40,4 |
Liabilities and provisions for liabilities | 1,3 | 0,5 | 0,4 | -28,5 |
Net income from sale | 0 | 0,2 | 0,2 | -9,7 |
Working assets | 1,4 | 0,6 | 0,4 | -25,3 |
Depreciation | ||||
% | % | % | p.p. | |
Profitability of capital | 87,6 | 46,7 | 2,3 | -44,4 |
Equity capital to total assets | 1,7 | 10,3 | 14,1 | 3,8 |
Gross profit margin | 82,6 | 16,7 | 2,2 | -14,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 20 511 | 1011 | 800 | -211 |
Current financial liquidity indicator | ||||
Net dept to EBITDA |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane